首页> 外文期刊>European review for medical and pharmacological sciences. >Long non-coding RNA GHET1 promotes viability, migration and invasion of glioma cell line U251 by down-regulation of miR-216a
【24h】

Long non-coding RNA GHET1 promotes viability, migration and invasion of glioma cell line U251 by down-regulation of miR-216a

机译:长非编码RNA GHET1通过下调miR-216a促进神经胶质瘤细胞系U251的活力,迁移和侵袭

获取原文
       

摘要

OBJECTIVE: Glioma is among the most aggressive of all human malignancies. Long non-coding RNA (lncRNA) gastric carcinoma highly expressed transcript 1 (GHET1) was considered an important oncogene in tumors. However, the role of GHET1 in glioma was rarely studied. The present work aimed to explore the effect of GHET1 on glioma cell line U251. MATERIALS AND METHODS: The viability, migration and invasion of U251 cells were analyzed by Cell Counting Kit-8 (CCK-8) assay, and transwell migration/invasion assay, respectively. The relative expression of GHET1 and miR-216a were detected by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). The expression of cell cycle-related proteins, cell metastasis-associated proteins and main factors in the JAK2/STAT3 and p53/survivin pathways was analyzed by Western blot. Cell transfection assay was conducted to alter expression of GHET1 and miR-216a in U251 cells. RESULTS: The viability, migration and invasion of U251 cells were promoted by GHET1 overexpression. The pro-cell cycle genes including Cyclin D1, CDK4 and CDK6, and the pro-metastasis genes including MMP-9 and Vimentin were up-regulated after GHET1 was overexpressed. MiR-216a was found to be down-regulated by GHET1 overexpression, and it was involved in the effects of GHET1 on U251 cells. GHET1 might promote U251 cells by down-regulating miR-216a. Finally, we found that GHET1 overexpression activated the JAK2/STAT3 and p53/survivin signaling pathways by down-regulating miR-216a. CONCLUSIONS: GHET1 overexpression increased viability, migration and invasion of U251 cells by down-regulating miR-216a. Mechanically, GHET1-miR-216a axis activated the JAK2/STAT3 and p53/survivin signaling pathways.
机译:目的:神经胶质瘤是所有人类恶性肿瘤中最具攻击性的。长非编码RNA(lncRNA)胃癌高表达的转录本1(GHET1)被认为是肿瘤中重要的癌基因。但是,很少研究GHET1在神经胶质瘤中的作用。本工作旨在探讨GHET1对神经胶质瘤细胞U251的影响。材料与方法:分别用Cell Counting Kit-8(CCK-8)分析法和Transwell迁移/侵袭分析法分析U251细胞的活力,迁移和侵袭。通过定量实时聚合酶链反应(qRT-PCR)检测GHET1和miR-216a的相对表达。 Western blot分析了JAK2 / STAT3和p53 / survivin途径中与细胞周期相关蛋白,细胞转移相关蛋白及主要因子的表达。进行细胞转染测定以改变U251细胞中GHET1和miR-216a的表达。结果:GHET1的过表达促进了U251细胞的活力,迁移和侵袭。 GHET1过表达后,包括Cyclin D1,CDK4和CDK6在内的前细胞周期基因以及包括MMP-9和Vimentin在内的前转移基因被上调。发现MiR-216a被GHET1过表达下调,并且参与了GHET1对U251细胞的作用。 GHET1可能通过下调miR-216a来促进U251细胞。最后,我们发现GHET1的过表达通过下调miR-216a激活了JAK2 / STAT3和p53 / survivin信号通路。结论:GHET1的过表达通过下调miR-216a来增加U251细胞的活力,迁移和侵袭。在机械上,GHET1-miR-216a轴激活了JAK2 / STAT3和p53 / survivin信号通路。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号